Related Experiment Video
Updated: Oct 3, 2025

09:44
Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
Published on: April 12, 2011
81.8K
Case Study of an Elderly Patient With New Onset Weakness
Journal of Clinical Neuromuscular Disease
|February 21, 2022
Summary
This case study highlights a patient with progressive muscle weakness diagnosed with primary systemic carnitine deficiency. Prompt L-Carnitine supplementation led to significant clinical improvement, underscoring its therapeutic role.
Area of Science:
- Neurology
- Metabolic Disorders
- Muscle Physiology
Background:
- Systemic carnitine deficiency is a rare metabolic disorder affecting fatty acid oxidation.
- It can manifest with diverse clinical symptoms, including muscle weakness.
Observation:
- A patient presented with new-onset progressive proximal muscle weakness in upper and lower limbs.
- Examination revealed preserved reflexes and no sensory involvement, with elevated creatine kinase levels.
- Electromyography showed myopathic features and myotonic discharges.
Findings:
- Muscle biopsy revealed vacuolization and increased fat content.
- Significantly reduced carnitine levels and elevated carnitine palmitoyltransferase confirmed systemic carnitine deficiency.
- No secondary causes were identified, suggesting a primary deficiency.
Implications:
- This case underscores the importance of considering metabolic myopathies in patients with unexplained proximal weakness.
- Early diagnosis and L-Carnitine supplementation are crucial for managing primary systemic carnitine deficiency.
- This highlights the critical role of carnitine in muscle energy metabolism.
More Related Videos
Related Concept Videos
Disorders of the Skeletal Muscle
1.2K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.2K
Myasthenia Gravis: Diagnostic Tests
1.5K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.5K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
46
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
46
Myasthenia Gravis: Overview and Treatment
2.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.1K
Cardiomyopathy VI: Nursing Management
65
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
65

